Murakami Y - Search Results

1

Predicting response to sepantronium bromide (YM155), a survivin suppressant, by PET imaging with [¹¹C]YM155.

Mitsuoka K, Kita A, Murakami Y, Shirasuna K, Noda A, Yamanaka K, Kaneko N, Miyoshi S. Mitsuoka K, et al. Among authors: murakami y. Nucl Med Biol. 2018 Sep-Oct;64-65:41-46. doi: 10.1016/j.nucmedbio.2018.06.005. Epub 2018 Jun 27. Nucl Med Biol. 2018. PMID: 30041149

2

Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques.

Noda A, Fushiki H, Murakami Y, Sasaki H, Miyoshi S, Kakuta H, Nishimura S. Noda A, et al. Among authors: murakami y. Nucl Med Biol. 2012 Nov;39(8):1232-5. doi: 10.1016/j.nucmedbio.2012.06.012. Epub 2012 Aug 11. Nucl Med Biol. 2012. PMID: 22890047

3

Radiosynthesis, biodistribution and imaging of [11C]YM155, a novel survivin suppressant, in a human prostate tumor-xenograft mouse model.

Murakami Y, Matsuya T, Kita A, Yamanaka K, Noda A, Mitsuoka K, Nakahara T, Miyoshi S, Nishimura S. Murakami Y, et al. Nucl Med Biol. 2013 Feb;40(2):221-6. doi: 10.1016/j.nucmedbio.2012.10.002. Epub 2012 Nov 7. Nucl Med Biol. 2013. PMID: 23141550

4

Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain.

Matsuya T, Takamatsu H, Murakami Y, Noda A, Ichise R, Awaga Y, Nishimura S. Matsuya T, et al. Among authors: murakami y. Nucl Med Biol. 2005 Nov;32(8):837-44. doi: 10.1016/j.nucmedbio.2005.06.008. Nucl Med Biol. 2005. PMID: 16253808

5

PET measurement of FK506 concentration in a monkey model of stroke.

Murakami Y, Takamatsu H, Noda A, Osoda K, Nishimura S. Murakami Y, et al. Nucl Med Biol. 2007 Aug;34(6):703-7. doi: 10.1016/j.nucmedbio.2007.05.007. Nucl Med Biol. 2007. PMID: 17707811

6

Cancer detection using a PET tracer, 11C-glycylsarcosine, targeted to H+/peptide transporter.

Mitsuoka K, Miyoshi S, Kato Y, Murakami Y, Utsumi R, Kubo Y, Noda A, Nakamura Y, Nishimura S, Tsuji A. Mitsuoka K, et al. Among authors: murakami y. J Nucl Med. 2008 Apr;49(4):615-22. doi: 10.2967/jnumed.107.048231. Epub 2008 Mar 14. J Nucl Med. 2008. PMID: 18344442 Free article.

7

Brain adenosine A2A receptor occupancy by a novel A1/A2A receptor antagonist, ASP5854, in rhesus monkeys: relationship to anticataleptic effect.

Mihara T, Noda A, Arai H, Mihara K, Iwashita A, Murakami Y, Matsuya T, Miyoshi S, Nishimura S, Matsuoka N. Mihara T, et al. Among authors: murakami y. J Nucl Med. 2008 Jul;49(7):1183-8. doi: 10.2967/jnumed.108.051474. Epub 2008 Jun 13. J Nucl Med. 2008. PMID: 18552135 Free article.

8

Pre-clinical validation of orthotopically-implanted pulmonary tumor by imaging with 18F-fluorothymidine-positron emission tomography/computed tomography.

Fushiki H, Miyoshi S, Noda A, Murakami Y, Sasaki H, Jitsuoka M, Mitsuoka K, Matsunari I, Nishimura S. Fushiki H, et al. Among authors: murakami y. Anticancer Res. 2013 Nov;33(11):4741-9. Anticancer Res. 2013. PMID: 24222108

9

PET imaging for tyrosine kinase inhibitor (TKI) biodistribution in mice.

Fushiki H, Murakami Y, Miyoshi S, Nishimura S. Fushiki H, et al. Among authors: murakami y. Methods Mol Biol. 2015;1219:199-206. doi: 10.1007/978-1-4939-1661-0_15. Methods Mol Biol. 2015. PMID: 25308271

10

Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys.

Campbell DO, Noda A, Verlinsky A, Snyder J, Fujita Y, Murakami Y, Fushiki H, Miyoshi S, Lacayo S, Cabral E, Yang P, Stover DR, Joseph IB. Campbell DO, et al. Among authors: murakami y. Mol Imaging Biol. 2016 Oct;18(5):768-75. doi: 10.1007/s11307-016-0953-x. Mol Imaging Biol. 2016. PMID: 27122234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,159 results

Search Page

Filters